- Home
- NSPR vs NVNO Comparison
NSPR vs NVNO Comparison
Compare NSPR & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSPR
- NVNO
- Stock Information
- Founded
- NSPR 2005
- NVNO 1987
- Country
- NSPR Israel
- NVNO United States
- Employees
- NSPR N/A
- NVNO N/A
- Industry
- NSPR Medical/Dental Instruments
- NVNO Medical/Dental Instruments
- Sector
- NSPR Health Care
- NVNO Health Care
- Exchange
- NSPR Nasdaq
- NVNO Nasdaq
- Market Cap
- NSPR 63.0M
- NVNO 51.7M
- IPO Year
- NSPR N/A
- NVNO N/A
- Fundamental
- Price
- NSPR $2.93
- NVNO $2.73
- Analyst Decision
- NSPR Strong Buy
- NVNO
- Analyst Count
- NSPR 2
- NVNO 0
- Target Price
- NSPR $4.75
- NVNO N/A
- AVG Volume (30 Days)
- NSPR 78.6K
- NVNO 137.6K
- Earning Date
- NSPR 11-12-2024
- NVNO 10-31-2024
- Dividend Yield
- NSPR N/A
- NVNO N/A
- EPS Growth
- NSPR N/A
- NVNO N/A
- EPS
- NSPR N/A
- NVNO N/A
- Revenue
- NSPR $6,821,000.00
- NVNO N/A
- Revenue This Year
- NSPR $13.31
- NVNO N/A
- Revenue Next Year
- NSPR $52.91
- NVNO N/A
- P/E Ratio
- NSPR N/A
- NVNO N/A
- Revenue Growth
- NSPR 24.70
- NVNO N/A
- 52 Week Low
- NSPR $1.81
- NVNO $2.74
- 52 Week High
- NSPR $3.42
- NVNO $6.97
- Technical
- Relative Strength Index (RSI)
- NSPR 52.69
- NVNO 30.94
- Support Level
- NSPR $2.78
- NVNO $2.90
- Resistance Level
- NSPR $3.15
- NVNO $2.93
- Average True Range (ATR)
- NSPR 0.22
- NVNO 0.16
- MACD
- NSPR -0.03
- NVNO -0.02
- Stochastic Oscillator
- NSPR 47.58
- NVNO 5.45
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).